Publication Date
10-29-2023
Content Type
Article
PubMed ID:
Citation
Bahlis, N. J., Costello, C. L., Raje, N. S., Levy, M. Y., Dholaria, B., Solh, M., Tomasson, M. H., Damore, M. A., Jiang, S., Basu, C., Skoura, A., Chan, E. M., Trudel, S., Jakubowiak, A., Gasparetto, C., Chu, M. P., Dalovisio, A., Sebag, M., & Lesokhin, A. M. (2023). Elranatamab in relapsed or refractory multiple myeloma: the MagnetisMM-1 phase 1 trial. Nature medicine, 29(10), 2570–2576. https://doi.org/10.1038/s41591-023-02589-w
Restricted
Available to BHSF community via local IP address or BHSF login.